Wall Street Zen upgraded shares of Dolby Laboratories (NYSE:DLB – Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning.
Other research analysts have also recently issued reports about the company. Barrington Research dropped their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 15th. Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $92.00.
Check Out Our Latest Stock Analysis on Dolby Laboratories
Dolby Laboratories Stock Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.2%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. Dolby Laboratories’s payout ratio is currently 54.75%.
Insiders Place Their Bets
In other Dolby Laboratories news, SVP John D. Couling sold 7,273 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $68.75, for a total transaction of $500,018.75. Following the transaction, the senior vice president directly owned 108,065 shares in the company, valued at approximately $7,429,468.75. This represents a 6.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $65.55, for a total transaction of $196,650.00. Following the sale, the senior vice president directly owned 67,435 shares of the company’s stock, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 162,120 shares of company stock valued at $10,906,559. Insiders own 37.93% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of DLB. Allworth Financial LP increased its stake in Dolby Laboratories by 99.6% in the third quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after purchasing an additional 502 shares in the last quarter. Swiss Life Asset Management Ltd bought a new stake in Dolby Laboratories in the 3rd quarter valued at about $210,000. Advisory Services Network LLC acquired a new position in Dolby Laboratories during the 3rd quarter worth approximately $102,000. XTX Topco Ltd bought a new position in Dolby Laboratories in the third quarter worth approximately $741,000. Finally, Verition Fund Management LLC grew its stake in Dolby Laboratories by 172.4% in the third quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock valued at $2,563,000 after acquiring an additional 22,409 shares during the period. 58.56% of the stock is owned by institutional investors.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
See Also
- Five stocks we like better than Dolby Laboratories
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Can Any Expenses Be Deducted From Capital Gains Tax?
- The Last Gold Bull Market
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
